ANTARES PHARMA INC's ticker is and the CUSIP is 036642956.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -80.0% | 300 | -78.6% | 0.00% | – |
| Q4 2021 | $5,000 | -61.5% | 1,400 | -61.1% | 0.00% | – |
| Q3 2021 | $13,000 | -95.0% | 3,600 | -93.9% | 0.00% | – |
| Q2 2021 | $259,000 | -3.4% | 59,400 | -8.8% | 0.00% | – |
| Q1 2021 | $268,000 | +62.4% | 65,100 | +57.6% | 0.00% | – |
| Q4 2020 | $165,000 | +126.0% | 41,300 | +53.5% | 0.00% | – |
| Q3 2020 | $73,000 | +62.2% | 26,900 | +64.0% | 0.00% | – |
| Q2 2020 | $45,000 | -69.8% | 16,400 | -74.1% | 0.00% | -100.0% |
| Q1 2020 | $149,000 | -67.3% | 63,200 | -34.8% | 0.00% | -66.7% |
| Q4 2019 | $455,000 | +17.3% | 96,900 | -16.5% | 0.00% | 0.0% |
| Q3 2019 | $388,000 | +193.9% | 116,100 | +190.2% | 0.00% | +200.0% |
| Q2 2019 | $132,000 | -60.4% | 40,000 | -63.6% | 0.00% | -75.0% |
| Q1 2019 | $333,000 | +35.4% | 109,900 | +21.7% | 0.00% | +100.0% |
| Q4 2018 | $246,000 | +146.0% | 90,300 | +203.0% | 0.00% | +100.0% |
| Q3 2018 | $100,000 | +284.6% | 29,800 | +192.2% | 0.00% | – |
| Q2 2018 | $26,000 | -40.9% | 10,200 | -48.5% | 0.00% | – |
| Q1 2018 | $44,000 | +12.8% | 19,800 | +2.1% | 0.00% | – |
| Q4 2017 | $39,000 | +550.0% | 19,400 | +1041.2% | 0.00% | – |
| Q3 2017 | $6,000 | -25.0% | 1,700 | -32.0% | 0.00% | – |
| Q2 2017 | $8,000 | -97.5% | 2,500 | -96.8% | 0.00% | -100.0% |
| Q2 2013 | $325,000 | – | 78,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|